These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32707039)

  • 1. Mimicry of a Non-ribosomally Produced Antimicrobial, Brevicidine, by Ribosomal Synthesis and Post-translational Modification.
    Zhao X; Li Z; Kuipers OP
    Cell Chem Biol; 2020 Oct; 27(10):1262-1271.e4. PubMed ID: 32707039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering lanthipeptides by introducing a large variety of RiPP modifications to obtain new-to-nature bioactive peptides.
    Fu Y; Xu Y; Ruijne F; Kuipers OP
    FEMS Microbiol Rev; 2023 May; 47(3):. PubMed ID: 37096385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Total Chemical Synthesis and Biological Evaluation of the Cationic Antimicrobial Peptides, Laterocidine and Brevicidine.
    Hermant Y; Palpal-Latoc D; Kovalenko N; Cameron AJ; Brimble MA; Harris PWR
    J Nat Prod; 2021 Aug; 84(8):2165-2174. PubMed ID: 34338512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and mechanism of lanthipeptide biosynthetic enzymes.
    van der Donk WA; Nair SK
    Curr Opin Struct Biol; 2014 Dec; 29():58-66. PubMed ID: 25460269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Structure-Activity Relationship Study, Bioactivity, and Nephrotoxicity Evaluation of the Proposed Structure of the Cyclic Lipodepsipeptide Brevicidine B.
    Palpal-Latoc D; Horsfall AJ; Cameron AJ; Campbell G; Ferguson SA; Cook GM; Sander V; Davidson AJ; Harris PWR; Brimble MA
    J Nat Prod; 2024 Apr; 87(4):764-773. PubMed ID: 38423998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BrevicidineB, a New Member of the Brevicidine Family, Displays an Extended Target Specificity.
    Zhao X; Kuipers OP
    Front Microbiol; 2021; 12():693117. PubMed ID: 34177875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of chemical synthesis in developing RiPP antibiotics.
    Rowe SM; Spring DR
    Chem Soc Rev; 2021 Apr; 50(7):4245-4258. PubMed ID: 33635302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine.
    Zhao X; Zhong X; Yang S; Deng K; Liu L; Song X; Zou Y; Li L; Zhou X; Jia R; Lin J; Tang H; Ye G; Yang J; Zhao S; Lang Y; Wan H; Yin Z; Kuipers OP
    Antimicrob Agents Chemother; 2023 May; 67(5):e0001023. PubMed ID: 36912655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RiPP antibiotics: biosynthesis and engineering potential.
    Hudson GA; Mitchell DA
    Curr Opin Microbiol; 2018 Oct; 45():61-69. PubMed ID: 29533845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A scalable platform to discover antimicrobials of ribosomal origin.
    Ayikpoe RS; Shi C; Battiste AJ; Eslami SM; Ramesh S; Simon MA; Bothwell IR; Lee H; Rice AJ; Ren H; Tian Q; Harris LA; Sarksian R; Zhu L; Frerk AM; Precord TW; van der Donk WA; Mitchell DA; Zhao H
    Nat Commun; 2022 Oct; 13(1):6135. PubMed ID: 36253467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free biosynthesis and engineering of ribosomally synthesized lanthipeptides.
    Liu WQ; Ji X; Ba F; Zhang Y; Xu H; Huang S; Zheng X; Liu Y; Ling S; Jewett MC; Li J
    Nat Commun; 2024 May; 15(1):4336. PubMed ID: 38773100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian Commensal
    He Y; Fan A; Han M; Li H; Li M; Fan H; An X; Song L; Zhu S; Tong Y
    Biochemistry; 2023 Jan; 62(2):462-475. PubMed ID: 36577516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Engineering in Ribosomally Synthesized and Post-translationally Modified Peptides (RiPPs).
    Do T; Link AJ
    Biochemistry; 2023 Jan; 62(2):201-209. PubMed ID: 35006671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining.
    Li YX; Zhong Z; Zhang WP; Qian PY
    Nat Commun; 2018 Aug; 9(1):3273. PubMed ID: 30115920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of protein-protein interactions in the biosynthesis of ribosomally synthesized and post-translationally modified peptides.
    Sikandar A; Koehnke J
    Nat Prod Rep; 2019 Nov; 36(11):1576-1588. PubMed ID: 30920567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome mining for ribosomally synthesized and post-translationally modified peptides (RiPPs) in anaerobic bacteria.
    Letzel AC; Pidot SJ; Hertweck C
    BMC Genomics; 2014 Nov; 15(1):983. PubMed ID: 25407095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel fungal RiPP biosynthetic pathways and their application for the development of peptide therapeutics.
    Vogt E; Künzler M
    Appl Microbiol Biotechnol; 2019 Jul; 103(14):5567-5581. PubMed ID: 31147756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of new-to-nature ribosomally synthesized and post-translationally modified peptide natural products.
    Wu C; van der Donk WA
    Curr Opin Biotechnol; 2021 Jun; 69():221-231. PubMed ID: 33556835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel antimicrobial peptide with broad-spectrum and exceptional stability derived from the natural peptide Brevicidine.
    Yang P; Mao W; Zhang J; Yang Y; Zhang F; Ouyang X; Li B; Wu X; Ba Z; Ran K; Tian Y; Liu H; Zhang Y; Gou S; Zhong C; Ni J
    Eur J Med Chem; 2024 Apr; 269():116337. PubMed ID: 38537511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Darobactin Class of Antibiotics: A Comprehensive Review from Discovery to Recent Advancements.
    Dutta A; Sharma P; Dass D; Yarlagadda V
    ACS Infect Dis; 2024 Aug; 10(8):2584-2599. PubMed ID: 39028949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.